InterMune Oritavancin Marketing Will Quadruple Firm's Sales Force To 200
InterMune will add 150 sales representatives to its 48-person U.S. force over the next three years for launch of Lilly's glycopeptide antibiotic oritavancin.
InterMune will add 150 sales representatives to its 48-person U.S. force over the next three years for launch of Lilly's glycopeptide antibiotic oritavancin.